Complete the USP medicare model guidelines version 10.0 - the united states pharmacopeial convention, INC. (USP), as stipulated by the medicare prescription drug improvement and modernization act of…

The United States Pharmacopeial Convention, Inc. (USP) received a $100,000 Cooperative Agreement from the Centers for Medicare and Medicaid Services (CMS) under the Congressional Directives program (CFDA 93.493), awarded on September 22, 2025, with a completion date of September 21, 2026. Under this agreement, USP will develop and complete Medicare Model Guidelines (MMG) Version 10.0, continuing a longstanding collaborative effort mandated by the Medicare Prescription Drug Improvement and Modernization Act of 2003. This updated guideline version will support CMS's mission to provide high-quality, cost-effective care to Medicare beneficiaries.

USP's deliverable represents the continuation of a triennial review process, building upon previously completed versions 8.0 and 9.0 of the MMG. The organization will leverage its expertise as an independent, science-based public health entity that sets standards for the identity, quality, and safety of medicines and related products. The completed MMG Version 10.0 will serve as a critical tool for CMS in establishing and maintaining pharmaceutical standards and guidelines applicable to Medicare prescription drug programs.

Complete the USP medicare model guidelines version 10.0 - the united states pharmacopeial convention, INC. (USP), as stipulated by the medicare prescription drug improvement and modernization act of 2003, works with the centers for medicare and medicaid services (CMS) to regularly revise and update the medicare model guideline (MMG). USP developed MMG version 1.0 in 2004, and in subsequent years entered into annual cooperative agreements with CMS that resulted in MMG versions 2.0, 3.0, 4.0, 5.0, 6.0, and 7.0. Versions 2.0, 3.0, and 4.0 were part of a continuous revision process, while versions 5.0, 6.0, 7.0, 8.0, and 9.0 represent a triennial review process. USP is now prepared to develop MMG version 10.0, supporting CMS efforts to provide high-quality, cost-effective care to beneficiaries. Please see attachment for comprehensive project abstract.